quinidine has been researched along with acecainide in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (60.87) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 2 (8.70) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akazawa, M; Inui, K; Okuda, M; Saito, H; Urakami, Y | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kanno, M; Komeichi, K; Nakaya, H; Shimizu, M; Tohse, N; Zhu, MY | 1 |
| Hoffman, BF; Roden, DM; Thompson, KA; Woosley, RL | 1 |
| Okumura, K; Waldo, AL | 1 |
| Audino, N; Burris, S; Haver, VM; Nelson, M | 1 |
| Feld, GK; Nademanee, K; Noll, E; Singh, BN | 1 |
| Roden, DM; Woosley, RL | 3 |
| Amsterdam, EA; Gallaher, C; Henderson, GL; Low, RI; Mason, DT | 1 |
| Lalka, D; McNamara, PJ; Pieper, JA; Slaughter, RL; Wyman, MG | 1 |
| Lasky, FD; Wesley, JF | 1 |
| Ho-Tung, P; Kessler, KM; Myerburg, RJ; Narayanan, S; Pickoff, A; Silver, J; Steele, B | 1 |
| McKinney, TD; Speeg, KV | 1 |
| Howanitz, JH; Howanitz, PJ | 1 |
| Curry, RW; Grauer, K; Kravitz, L; Lopez, LM; Robinson, JD; Sands, CR | 1 |
| Lam, YW; Watkins, CE | 1 |
| Flarakos, J; Morand, KL; Vouros, P | 1 |
2 review(s) available for quinidine and acecainide
| Article | Year |
|---|---|
Antiarrhythmic drug monitoring.
Topics: Acecainide; Anti-Arrhythmia Agents; Disopyramide; Humans; Lidocaine; Phenytoin; Procainamide; Propranolol; Quinidine | 1981 |
Class I antiarrhythmic agents: quinidine, procainamide and N-acetylprocainamide, disopyramide.
Topics: Acecainide; Animals; Anti-Arrhythmia Agents; Disopyramide; Drug Interactions; Electrocardiography; Electrophysiology; Humans; Kinetics; Procainamide; Quinidine | 1983 |
1 trial(s) available for quinidine and acecainide
| Article | Year |
|---|---|
Oral N-acetylprocainamide compared to quinidine plus digoxin in the chronic suppression of atrial flutter in humans.
Topics: Acecainide; Action Potentials; Aged; Atrial Flutter; Digoxin; Drug Therapy, Combination; Humans; Male; Middle Aged; Quinidine; Random Allocation | 1989 |
20 other study(ies) available for quinidine and acecainide
| Article | Year |
|---|---|
cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney.
Topics: Alternative Splicing; Amino Acid Sequence; Base Sequence; Cations; Cell Line; Cloning, Molecular; DNA, Complementary; Genetic Variation; Humans; Kidney; Molecular Sequence Data; Organic Cation Transport Proteins; Organic Cation Transporter 2; Tetraethylammonium; Tissue Distribution; Transfection | 2002 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of N-acetylprocainamide and sotalol on ion currents in isolated guinea-pig ventricular myocytes.
Topics: Acecainide; Action Potentials; Animals; Electric Stimulation; Female; Guinea Pigs; Heart; Ion Channels; Male; Membranes; Myocardium; Papillary Muscles; Potassium Channels; Quinidine; Sotalol | 1990 |
Clinical features and basic mechanisms of quinidine-induced arrhythmias.
Topics: Acecainide; Action Potentials; Animals; Bradycardia; Dogs; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Purkinje Fibers; Quinidine; Rabbits; Tachycardia; Time Factors | 1986 |
Effects of N-acetylprocainamide on experimental atrial flutter and atrial electrophysiologic properties in conscious dogs with sterile pericarditis: comparison with the effects of quinidine.
Topics: Acecainide; Animals; Atrial Flutter; Consciousness; Differential Threshold; Dogs; Electrophysiology; Heart; Heart Atria; Heart Conduction System; Pericarditis; Procainamide; Quinidine; Refractory Period, Electrophysiological; Time Factors | 1987 |
Four fluorescence polarization immunoassays for therapeutic drug monitoring evaluated.
Topics: Acecainide; Fluorescence Polarization; Humans; Immunoassay; Phenytoin; Procainamide; Quality Control; Quinidine | 1989 |
QT prolongation and arrhythmia suppression.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Deafness; Death, Sudden; Electrocardiography; Heart Atria; Heart Ventricles; Humans; Quinidine; Sotalol; Systole; Tachycardia | 1985 |
Comparison of high-performance liquid chromatography with an enzyme multiplied immunoassay technique for the analysis of serum procainamide and N-acetylprocainamide.
Topics: Acecainide; Arrhythmias, Cardiac; Chromatography, High Pressure Liquid; Drug Interactions; Humans; Immunoenzyme Techniques; Lidocaine; Procainamide; Quinidine | 1980 |
Factors influencing serum protein binding of lidocaine in humans.
Topics: Acecainide; Blood Proteins; Bupivacaine; Disopyramide; Humans; Lidocaine; Orosomucoid; Procainamide; Propranolol; Protein Binding; Quinidine; Serum Albumin | 1981 |
High performance liquid chromatographic analysis of the antiarrhythmic drugs procainamide, disopyramide, quinidine, propranolol and metabolites from serum extracts.
Topics: Acecainide; Anti-Arrhythmia Agents; Chromatography, High Pressure Liquid; Disopyramide; Humans; Procainamide; Propranolol; Pyridines; Quinidine; Spectrophotometry, Ultraviolet | 1981 |
Simultaneous quantitation of quinidine, procainamide, and N-acetylprocainamide in serum by gas-liquid chromatography with a nitrogen-phosphorus selective detector.
Topics: Acecainide; Chromatography, Gas; Heart Arrest; Humans; Immunoenzyme Techniques; Procainamide; Quinidine | 1982 |
Cimetidine and procainamide secretion by proximal tubules in vitro.
Topics: Absorption; Acecainide; Animals; Carbon Dioxide; Chromatography, High Pressure Liquid; Cimetidine; Guanidines; Hypothermia; Kidney Tubules, Proximal; Kinetics; Ouabain; Probenecid; Procainamide; Quinidine; Rabbits | 1982 |
Importance of metabolites in antiarrhythmic therapy.
Topics: Acecainide; Agranulocytosis; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Encainide; Humans; Procainamide; Propranolol; Quinidine | 1983 |
Ventricular ectopy.
Topics: Acecainide; Administration, Oral; Adult; Age Factors; Aged; Cardiac Complexes, Premature; Delayed-Action Preparations; Electrocardiography; Female; Half-Life; Humans; Infusions, Parenteral; Kinetics; Lidocaine; Male; Middle Aged; Procainamide; Quinidine | 1984 |
Fluorescence polarization immunoassay of quinidine, procainamide, and N-acetylprocainamide using Cobas-FP reagents.
Topics: Acecainide; Drug Monitoring; Enzyme Multiplied Immunoassay Technique; Fluorescence Polarization Immunoassay; Humans; Procainamide; Quinidine; Reagent Kits, Diagnostic | 1993 |
High-throughput solution-based medicinal library screening against human serum albumin.
Topics: Acecainide; beta-Lactams; Chromatography, Gel; Chromatography, Liquid; Combinatorial Chemistry Techniques; Dansyl Compounds; Humans; Imipramine; Indomethacin; Pharmaceutical Preparations; Protein Binding; Quinidine; Reproducibility of Results; Sarcosine; Serum Albumin; Tandem Mass Spectrometry; Tryptophan; Warfarin | 2005 |